Successful Outcome of Advanced Pulmonary Adenocarcinoma With Malignant Pleural Effusion by the Standardized Rhus Verniciflua Stokes Extract: A Case Study

References 

1. Devita VT, Hellman S, Rosenberg SA. In: Cancer: Principles and Practice of Oncology. 6th ed.. Philadelphia, Pa: JB Lippincott; 2001;p. 925–927
2. Bunn PA, Thatcher N. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Oncologist. 2008;13:S1–S4
3. Fukuse T, Hirata T, Tanaka F, Wada H. The prognostic significance of malignant pleural effusion at the time of thoracotomy in patients with non-small cell lung cancer. Lung Cancer. 2001;34:75–81
   • Abstract
   • Full Text
   • Full-Text PDF (95 KB)
   • CrossRef
4. Jung NC. Biological Activity of Urushiol and Flavonoids From Lac Tree (Rhus Verniciflua Stokes). [PhD thesis] Gwangju, Republic of Korea: Chonnam National University; 1998;
5. Jang HS, Kook SH, Son YO, et al. Flavonoids purified from Rhus verniciflua Stokes actively inhibit cell growth and induce apoptosis in human osteosarcoma cells. Biochim Biophys Acta. 2005;1726:309–316
   • MEDLINE
6. Kitts DD, Lim KT. Antitumorigenic and cytotoxic properties of an ethanol extract derived from Rhus verniciflua Stokes (RVS). J Toxicol Env Health A. 2001;64:357–371
7. Lee JC, Lee KY, Kim J, et al. Extract from Rhus verniciflua Stokes is capable of inhibiting the growth of human lymphoma cells. Food Chem Toxicol. 2004;42:1383–1388
   • MEDLINE
   • CrossRef
8. Samoszuk M, Tan J, Chorn G. The chalcone butein from Rhus verniciflua Stokes inhibits clonogenic growth of human breast cancer cells co-cultured with fibroblasts. BMC Complement Altern Med. 2005;9:1–5
   • CrossRef
9. Son YO, Lee KY, Lee JC, et al. Selective antiproliferative and apoptotic effects of flavonoids purified from Rhus verniciflua Stokes on normal versus transformed hepatic cell lines. Toxicol Lett. 2005;155:115–125
   • MEDLINE
   • CrossRef
10. Collins LG, Haines C, Perkel R, Enck RE. Lung cancer: diagnosis and management. Am Fam Physician. 2007;75:56–63
    • MEDLINE
11. Sugiura S, Ando Y, Minami H, Ando M, Sakai S, Shimokata K. Prognostic value of pleural effusion in patients with non-small cell lung cancer. Clin Cancer Res. 1997;3:47–50
    • MEDLINE
12. Groome PA, Bolejack V, Crowley JJ, et al. IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:694–705
    • CrossRef
13. Perrone F, Di Maio M, Budillon A, Normanno N. Targeted therapies and non-small cell lung cancer: methodological and conceptual challenge for clinical trials. Curr Opin Oncol. 2005;17:123–129
    • MEDLINE
    • CrossRef
14. Lovell CR. Poison oak. In: Plants and the Skin. 1st ed.. Oxford, England: Blackwell Scientific Publications; 1993;p. 106–110
15. Choi WC, Sminova Z, Kubasova I, Baryshnikov A. Antitumor efficacy of the allergen-removed extract (ACM909Q) in Rhus verniciflua. Eur J Pharm Sci. 2002;17S:78–79
16. Choi WC, Lee JH, Lee EO, et al. Study on antiangiogenic and antitumor activities of processed Rhus verniciflua Stokes extract. Korean J Orient Physiol Pathol. 2006;20:825–829
17. Kook SH, Son YO, Chung SW, et al. Caspase-independent death of human osteosarcoma cells by flavonoids is driven by p53-mediated mitochondrial stress and nuclear translocation of AIF and endonuclease G. Apoptosis. 2007;12:1289–1298
    • MEDLINE
    • CrossRef
18. Kim JH, Go HY, Jin DH, et al. Inhibition of the PI3K-Akt/PKB survival pathway enhanced an ethanol extract of Rhus verniciflua Stokes-induced apoptosis via a mitochondrial pathway in AGS gastric cancer cell lines. Cancer Lett. 2008;265:197–205
    • Abstract
    • Full Text
    • Full-Text PDF (347 KB)
    • CrossRef